[Immunotherapy in sepsis syndrome]

Ned Tijdschr Geneeskd. 1992 May 30;136(22):1050-4.
[Article in Dutch]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Cytokines / antagonists & inhibitors
  • Endotoxins / pharmacology
  • Humans
  • Immunoglobulin M / therapeutic use
  • Immunotherapy / methods*
  • Interleukin-1 / antagonists & inhibitors
  • Macrophage Activation / drug effects
  • Shock, Septic / immunology
  • Shock, Septic / therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • Endotoxins
  • Immunoglobulin M
  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • nebacumab